National Cholesterol Education Program risk assessment and potential for risk misclassification

被引:15
作者
Persell, Stephen D.
Lloyd-Jones, Donald M.
Baker, David W.
机构
[1] Northwestern Univ, Div Gen Internal Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Cardiol, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
关键词
hypercholesterolemia; cardiovascular diseases; practice guidelines; risk; risk factors;
D O I
10.1016/j.ypmed.2006.06.017
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The National Cholesterol Education Program Adult Treatment Panel report from 2001 (ATP III) recommends clinicians calculate 10-year coronary risk using multivariable methods only for adults with 2 or more risk factors. We aimed to determine who would be falsely classified as low risk using this approach. Methods. We studied 4097 adults aged 20 to 79 years without diagnosed cardiovascular disease or diabetes from the National Health and Nutrition Examination Survey from 1999 to 2002. We determined the proportion with fewer than 2 risk factors who nonetheless had estimated 10-year risk of cardiac death or myocardial infarction >= 10% using multivariable methods. Results. Among persons with fewer than 2 risk factors, 5.3% (95% confidence interval 4.7 to 6.1%), had a 10-year risk >= 10% using the Framingham Risk Score and would be misclassified using the risk factor counting method (this corresponds to approximately 5,640,000 U.S. adults). Compared to individuals whose classification was unchanged, those misclassified as low risk were older (P < 0.001) and more likely male (85.5% vs. 41.2%, P < 0.001). Conclusions. Relying on the ATP III risk factor counting method rather than determining risk using multivariable methods in all patients resulted in misclassifiying as low risk over 5 million adults with at least moderately high risk of coronary heart disease, most of whom are middle-aged and older men. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:368 / 371
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 2005, NAT HLTH NUTR EX SUR
[2]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[3]  
Davidson MH, 2002, AM J CARDIOL, V89, p8C
[4]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[5]   Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals [J].
Greenland, P ;
LaBree, L ;
Azen, SP ;
Doherty, TM ;
Detrano, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (02) :210-215
[6]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[7]   Maximizing the cost-effectiveness of lipid-lowering therapy [J].
Jacobson, TA ;
Schein, JR ;
Williamson, A ;
Ballantyne, CM .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (18) :1977-1989
[8]   Accuracy of offspring reports of parental cardiovascular disease history: The Framingham offspring study [J].
Murabito, JM ;
Nam, BH ;
D'Agostino, RB ;
Lloyd-Jones, DM ;
O'Donnell, CJ ;
Wilson, PWF .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (06) :434-440
[9]  
*NAT HEART LUNG BL, 2006, RISK ASS TOOL EST 10